Estadístiques de Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain.

Visites totals

views
Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain. 302

Visites totals per mes

views
October 2024 0
November 2024 1
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

Visites al fitxer

views
sabater-ahe-cost.pdf(legacy) 590
sabater-ahe-cost.pdf 35

Vistes principals per país

views
United States 204
France 22
Germany 21
Spain 13
China 7
Ireland 6
United Kingdom 5
Sweden 4
Belgium 3
Poland 3
Italy 2
Russia 2
Slovenia 2
Ukraine 2
Canada 1
Czechia 1
Malaysia 1
New Zealand 1

Visites principals per ciutat

views
Ashburn 43
Fairfield 23
San Ramon 17
Mountain View 16
Cambridge 14
Ann Arbor 12
Boardman 11
Menlo Park 11
Sunnyvale 10
Dublin 6
Barcelona 5
Seattle 5
Beijing 3
Fremont 3
San Diego 3
Shenzhen 3
Redwood City 2
Rezé 2
San Mateo 2
Cupertino 1
Des Moines 1
Jacksonville 1
Kuala Lumpur 1
Magdeburg 1
Montréal 1
Munich 1
Phoenix 1
Premiá De Mar 1
San Jose 1
Torremolinos 1
Wellington 1
Wilmington 1